CureDiab has established a state-of-the-art cell and molecular biology laboratory equipped with an excellent asset of technologies for monitoring physiological cell functions and modulation by multiple reagents. This includes drugs and mediators of different diseases with a focus on metabolic disorders.
CureDiab is able to perform contract research projects and is able to execute multiple in vitro assays using primary human cells. This includes RNAseq, signaling analysis, digital microscopy and a broad spectrum of fluorescence-based assays, PCR, Western blot analysis and secretome studies using proteomic technologies.
Please contact us for more details, we offer detailed consulting by leading experts in molecular metabolism.